A kind of size-determined Wudan Fupian granule and its preparation method
A sizing and granule technology, applied in the field of Wudanfu Tablet granules and their preparation, can solve the problems of reduced clinical efficacy stability, obvious differences in the proportion of pulp, and low content of pulp, etc., and achieves enhancement, stability and controllability, and uniform specifications. , the effect of improving retention
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] The preparation (once drying) of embodiment 1 Wugaofu Tablets:
[0025] Take fresh aconite or refrigerated aconite, wash and remove the mud; use a CHD100 dicing machine to cut the aconite into 5mm×5mm×5mm particles, spread it on a large square plate in a single layer, and place it in a blast at 100°C In a drying box, dry with hot air for 10 hours to obtain the finished product.
Embodiment 2
[0026] The preparation of embodiment 2 gallbladder-free tablets (twice drying):
[0027] Take fresh aconite or refrigerated aconite, wash and remove the mud; use a CHD100 dicing machine to cut the aconite into 5mm×6mm×7mm particles, spread it on a large square plate in a single layer, and place it in a blast at 100°C In a drying oven, dry with hot air for 3 hours until the moisture content is below 10% to obtain an intermediate product, which is stored in a cool and ventilated place sealed. During subsequent processing, the intermediate product is taken out, and dried in a blast drying oven at 100°C for 7 hours with hot air to fully detoxify it to obtain a finished product.
Embodiment 3
[0028] Example 3 Comparison of the chemical composition of the gallbladder-free tablets prepared by the present invention and the commercially available tablets
[0029] The contents of 6 alkaloid components in 9 commercially available Fupian and Wudan Fupian granules prepared in Example 1 of the present invention were determined by HPLC, and the results are shown in Table 1.
[0030] As can be seen from Table 1, in terms of the sum of the contents of the monoester-type alkaloids of the medicinally active ingredients, the Wudanfu Tablets granules of the present invention>Steamed Fuzi>Heishun Tablets>Shengfu Tablets>Paofuzi>Baifuzi slices>fried slices>planed slices>Pao Tianxiong. The content of the medicinal active ingredient of the Wudanfupian granule of the present invention is much higher than the 0.01% standard stipulated in the Pharmacopoeia and is also much higher than other decoction pieces, which shows that the preparation method of the Wudanfupian granule of the presen...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


